Apr 6, 2026 | Emergency Room (ER), Food and Drug Administration (FDA), Government, News, Over-the-counter (OTC) drugs, Survey, Urgent Care
FDA Commissioner Marty Makary, MD, MPH, made expanding over-the-counter (OTC) availability of more drugs a clear priority during an April 1, 2026 press conference. “When I look at the reasons those drugs were not approved in the past, I think we can do better,” he...
Feb 9, 2026 | Discounts, News, Online Services, Pharmacy, TrumpRx
The February 5th launch of the TrumpRx.gov online portal has generated attention for its lower prescription drug pricing… and may offer value for self-funded pharmacy plans in cases where medications are excluded from coverage or members face high upfront costs. While...
Feb 6, 2026 | Cancer, MedBen WellLiving, News, Preventive Care
The fight against cancer has reached a major turning point. According to the American Cancer Society (ACS), seven in 10 people diagnosed with cancer in the U.S. now survive at least five years — a milestone that reflects decades of progress in prevention, detection,...
Jan 12, 2026 | Acquisition Cost Index (ACI) pricing, Biosimilars, Brand Name Drugs, Drug costs, High-value formulary, MedBen Rx, News, Patient assistance, Pharmacogenomics, Pharmacy
Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...
Jan 9, 2026 | Flu Shots, Influenza, News, Preventive Care, Vaccinations, Wellness
Earlier this fall, we shared a reminder about the importance of annual flu vaccination and early-season planning. That guidance still holds – but this year’s flu season has raised the stakes. According to the CDC, flu activity has reached its highest level in...
May 5, 2025 | Legislative, News, Pharmacy, Pharmacy Benefits Manager (PBM), State legislation
On April 16, Arkansas became the first state to ban pharmacy benefit managers (PBMs) from acquiring an interest in – or otherwise directly or indirectly holding a permit for the retail sale of – prescription drugs, including mail-order...
